Pancreatic cancer funding boost

By Hudson Institute communications

Congratulations to Professor Brendan Jenkins and his team, who have been awarded $288,536 from Cancer Council Victoria (CCV) to fund research into pancreatic cancer.

Professor Jenkins’ project was one of 13 projects to receive a share in $3.8 million in 2021 from CCV’s Grants-in-Aid program, which funds high-quality research into the treatment, causes, detection and prevention of all cancers.

The study will investigate a precision medicine approach to a form of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC). Researchers will examine a receptor in the body’s immune system which could potentially be targeted by therapies to fight tumours, including those that have become resistant to chemotherapy.

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry